Pascal Deschatelets - Net Worth and Insider Trading
Pascal Deschatelets Net Worth
The estimated net worth of Pascal Deschatelets is at least $36 Million dollars as of 2024-12-28. Pascal Deschatelets is the Chief Scientific Officer of Apellis Pharmaceuticals Inc and owns about 1,115,983 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $36 Million. Details can be seen in Pascal Deschatelets's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pascal Deschatelets has not made any transactions after 2024-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pascal Deschatelets
Pascal Deschatelets Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pascal Deschatelets owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Pascal Deschatelets’s form 4 insider trades.
Insider Ownership Summary of Pascal Deschatelets
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-05-08 | Chief Operating Officer |
Pascal Deschatelets Latest Holdings Summary
Pascal Deschatelets currently owns a total of 1 stock. Pascal Deschatelets owns 1,115,983 shares of Apellis Pharmaceuticals Inc (APLS) as of May 8, 2024, with a value of $36 Million.
Latest Holdings of Pascal Deschatelets
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-05-08 | 1,115,983 | 32.68 | 36,470,324 |
Holding Weightings of Pascal Deschatelets
Pascal Deschatelets Form 4 Trading Tracker
According to the SEC Form 4 filings, Pascal Deschatelets has made a total of 30 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 78,907 shares on May 8, 2024, which brought Pascal Deschatelets around $3 Million.
Insider Trading History of Pascal Deschatelets
- 1
Pascal Deschatelets Trading Performance
Pascal Deschatelets Ownership Network
Pascal Deschatelets Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Pascal Deschatelets is the Chief Operating Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks Jeffrey Eisele , General Counsel David O. Watson , and See Remarks James George Chopas .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Pascal Deschatelets made 12 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 284,688. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 433,087 shares made by Cedric Francois , a net sale of 33,060 shares made by Timothy Eugene Sullivan , and a net sale of 27,526 shares made by David O. Watson .
In summary, during the past 3 months, insiders sold 5,063 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,063 shares. During the past 18 months, 1,149,235 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,149,235 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Pascal Deschatelets Mailing Address
Above is the net worth, insider trading, and ownership report for Pascal Deschatelets. You might contact Pascal Deschatelets via mailing address: 6400 Westwind Way, Suite A, Crestwood Ky 40014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
